Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evergreen Organix is a Nevada-based cannabis company specializing in the production of premium medical and recreational cannabis products. Established in 2015, the company has built a reputation for high-quality extraction and consistent dosing across its diverse product line, which includes edibles, topicals, and concentrates. In 2019, Evergreen Organix was acquired by Flower One Holdings, integrating its operations into one of the largest cannabis cultivation and production facilities in the state. The company's therapeutic focus includes cannabinoid-based solutions for pain management, inflammation, and sleep disorders. Its products are widely available in dispensaries throughout Nevada, catering to both medical patients and adult-use consumers. Evergreen Organix continues to be a prominent brand in the regional cannabis market, emphasizing safety and efficacy in its formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evergreen Organix.